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Bone tissue engineering is an emerging field, representing one of the most exciting challenges for scientists and clinicians. The
possibility of combining mesenchymal stem cells and scaffolds to create engineered tissues has brought attention to a large
variety of biomaterials in combination with osteoprogenitor cells able to promote and regenerate bone tissue. Human adipose
tissue is officially recognized as an easily accessible source of mesenchymal stem cells (AMSCs), a significant factor for use in
tissue regenerative medicine. In this study, we analyze the behavior of a clonal finite cell line derived from human adipose tissue
seeded on poly(𝜀-caprolactone) (PCL) film, prepared by solvent casting. PCL polymer is chosen for its good biocompatibility,
biodegradability, and mechanical properties. We observe that AMSCs are able to adhere to the biomaterial and remain viable for
the entire experimental period. Moreover, we show that the proliferation process and osteogenic activity of AMSCs are maintained
on the biofilm, demonstrating that the selected biomaterial ensures cell colonization and the development of an extracellular
mineralized matrix. The results of this study highlight that AMSCs and PCL film can be used as a suitable model to support
regeneration of new bone for future tissue engineering strategies.
1. Introduction
The rapidly growing knowledge of cell biology and mate-
rial science has brought attention to the tissue engineer-
ing approach as a promising strategy, alternative to the
conventional autogenic or allogenic surgical techniques for
bone defects regeneration [1–3]. Tissue engineering is a
multidisciplinary field that is affected by three main agents
including cell source, scaffold biomaterial, and biochemical
agents. In particular, bone tissue engineering involves the
transplant of an appropriate scaffolding biomaterial alone
or in combination with cells, that is, osteoblast progenitors
and/or growth factors capable of osteogenic differentiation
necessary for bone repair and regeneration [3, 4].
In order to achieve the proposed aim, it is important to
select appropriate cell sources and biomaterials, since the cell-
scaffold interaction represents a crucial step for the success
of tissue engineering applications. One of the efforts in this
field is the use of mesenchymal stem cells (MSCs) as a
source for tissue engineering [5]. MSCs are undifferentiated,
nonhematopoietic cells of mesodermal derivation that are
present in a number of postnatal organs and connective
tissues, including bone marrow, trabecular bone, synovium,
umbilical cord, dental tissues, and skin [6–10], and have
the potential to differentiate into osteogenic, chondrogenic,
adipogenic, and endothelial lineages [11–14]. Bone marrow
mesenchymal stem cells (BMSCs) represent the most thor-
oughly studied source of MSCs for bone tissue regeneration.
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However, bone marrow is obtained through an invasive and
painful procedure.
In recent years, a promising population of MSCs has
been identifiedwithin adipose tissue, termed adipose-derived
mesenchymal stem cells (AMSCs). In fact, human adipose
is ubiquitous and can easily be obtained in large quantities
with very little donor site morbidity or patient discomfort.
Moreover, stem cell yields are greater fromadipose tissue than
from other stem cell reservoirs, a significant factor for use in
regenerative medicine, as many 1 × 107 AMSCs can routinely
be isolated from300mLof lipoaspirate, with greater than 95%
purity [15–18].
AMSCs have been extensively described in terms of stem-
ness [19, 20] and osteogenic differentiation capacity [18, 21],
andmany researchers have shown the potential use ofAMSCs
in combinationwith a variety of differentmaterials, including
ceramics, titan alloys, natural and synthetic polymers, and
natural or semisynthetic grafts for bone tissue engineering
[21–27], proposed for the treatment of bone pathological
conditions.
In our study, we decided to utilize the polyester poly(𝜀-
caprolactone) (PCL) in the form of film prepared by solvent
casting, since it is a nontoxic, biodegradable polymer, with a
slow degradation rate (months to years), which demonstrates
goodmechanical strength and biocompatibility [28–32]. PCL
has been widely investigated for different biomedical appli-
cations, such as drug delivery systems (nano- or micropar-
ticles), medical devices (e.g., sutures, wound dressing, con-
traceptive devices, and internal fixation devices), and tissue
engineering [33, 34].
Despite the publication of numerous reports on PCL for
bone tissue engineering destined for biomedical applications
[35–40], there is no literature describing the in vitro behavior
in terms of adhesion, vitality, proliferation, and osteogenic
differentiation of human AMSCs (hAMSCs) seeded onto
PCL film. Therefore, the objective of the study was to
demonstrate the potential of this cell-biomaterial model for
the proposed application, supporting and promoting the
research on hAMSCs and PCL in bone tissue engineering
strategies.
2. Materials and Methods
2.1. hAMSCs Cultures. hAMSCs line, named PA42, was
isolated from small fragments of subcutaneous adipose tissue
biopsy obtained during general surgery from a patient, after
signing an informed consent in accordance with a protocol
approved by the Local Ethics Committee of AOU-Careggi,
Firenze (Italy), for human studies (Rif.n.31-13). Briefly the
adipose tissue sample was minced into small pieces (0.5–
1mm) and digested for 3 hours at 37∘C in Ham’s F12 Coon’s
modification medium supplemented with 20% fetal bovine
serum (FBS) and 3mg/mL collagenase type I (C-0130, Sigma
Aldrich). The tissue was then mechanically dispersed by
pipetting and passed through a sterile 230 𝜇m stainless steel
tissue sieve. The undigested tissue trapped in the sieve was
discarded, while the infranatant containing the hAMSCs
fraction was collected and the cells were sedimented by cen-
trifugation at 300 g for 5min.The cells were resuspended and
primary culture was seeded in 100mm tissue culture plates
at 37∘C in humidified atmosphere with 5% CO
2
in medium
thus composed: Ham’s F12 Coon’s modification medium sup-
plemented with 20% FBS, 100 IU/mL penicillin, 100𝜇g/mL
streptomycin, and 1 ng/mL basic Fibroblast Growth Factor
(bFGF). The medium was refreshed twice a week and the
cells were used for further subculturing or cryopreservation
upon reaching 5 × 103 cells/cm2. From this point, primary
culture was expanded in growth medium (GM), Ham’s F12
Coon’s modification medium supplemented with 10% FBS,
100 IU/mL penicillin, 100 𝜇g/mL streptomycin, and 1 ng/mL
basic Fibroblast Growth Factor (bFGF), and/or differenti-
ated in specified medium according to the experimental
protocol.
2.2. hAMSCs Cloning. PA42 cells at the 3rd passage were
used for cell cloning. Cells in an active phase of growth were
cloned by the dilution plating technique. Cells were detached
with trypsin 1 : 250 0.4mg/mL in Dulbecco’s Phosphate
Buffered Saline (DPBS) without Ca2+ without Mg2+ with
EDTA 0.2mg/mL and with glucose 1mg/mL, resuspended in
Coon’s medium + 20% FCS. The cell suspension was diluted
to a concentration of 10 cells/mL in the following cloning
medium: Coon’s and 20% FCS supplemented with 25%
conditioned medium prepared from human fetal fibroblast
culture. The cell suspension was maintained in agitation and
0.1mL was rapidly distributed per well of a 96-well, half area
tissue culture plate. Each well was carefully observed and
the wells containing only one cell were scored. The cloning
culture was incubated at 37∘C in humidified air with 5%CO
2
.
When colonies reached the consistency of 500–1000 cells,
they were detached, collected, and first transferred in 24-
well plates and subsequently expanded in 60mmand 100mm
dishes.
2.3. Soft Agar Assay for Neoplastic Transformation. Neoplas-
tic transformed cells form colonies that grow progressively
in soft agar. A 35mm dish was coated with 1% agar prepared
in culture medium maintained liquid at 45∘C. The dish was
immediately cooled. Cells in growth phase were detached,
suspended in medium, diluted to double the required final
concentration, and maintained at 37∘C. 0.68% agar was
prepared inmedium andmaintained at 45∘C. Cell suspension
was mixed with an equal volume of 0.68% agar, distributed
into the agar coated dish to obtain a final concentration of
2.5 × 103 cells/dish, and immediately cooled. The cells were
cultured at 37∘C in humidified air with 5% CO
2
for 3-4 weeks
until the formation of colonies and their growth. Colonies
formed per dish were observed and counted in phase contrast
microscopy.
2.4. hAMSCs Characterization and Multipotency Evaluation.
The characterization of the PA42 cell line and the finite
clonal cell line, named PA42-C4, was performed by immuno-
cytochemical staining of the main stemness markers of
mesenchymal stem cells (CD44, CD105, and STRO1) and by
studying their multipotency toward both the adipogenic and
osteogenic phenotypes, as described below.
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2.4.1. Immunocytochemical Staining. PA42-C4 finite clonal
line was seeded in 24-well plate and grown in GM until
23–30% confluence. Then, cells were washed with DPBS
(two times), fixed in 4% paraformaldehyde PFA/DPBS for
10min, and washed with ultrapure water (three times). After
permeabilization with 0.2% PBS 1x/Triton X-100 solution for
15min and treatment with RNAse, samples were incubated
with primary antibody for CD44, CD105, STRO1, and CD45
(all Invitrogen) in PBS at 4∘C, overnight. The following day,
primary antibody was removed by extensive washes with
PBS and secondary antibody Alexa Fluor 488-conjugated
(Invitrogen) was incubated for 1 h at room temperature in
the dark. Subsequently, samples were washed with PBS and
observed by Laser Scanning Confocal Microscopy (LSCM).
2.4.2. Adipogenic Differentiation. PA42 cell line and PA42-
C4 finite clonal line were cultured with a specific adipogenic
medium (AM): Ham’s F12 Coon’s modification medium sup-
plemented with 10% (FBS), 100 IU/mL penicillin, 100 𝜇g/mL
streptomycin and 1 𝜇M dexamethasone, 1 𝜇M bovine insulin,
and 0.5mM isobutylmethylxanthine (IBMX). The medium
was refreshed twice a week.The expression of the adipogenic
phenotype was evaluated on cells cultured in AM or GM for
20 days by Oil Red O staining.
2.4.3. Osteogenic Differentiation. PA42 cell line and PA42-C4
finite clonal line were plated on tissue culture dishes at a cell
density of 1 × 104 cells/cm2 in GM and grown to 70–80% con-
fluence. Afterwards, the medium was switched to osteogenic
medium (OM): Ham’s F12 Coon’s modification medium sup-
plemented with 10% FBS, 100 IU/mL penicillin, 100 𝜇g/mL
streptomycin, 10 nM dexamethasone, 0.2mM sodium L-
ascorbyl-2-phosphate, and 10mM 𝛽-glycerol phosphate. The
medium was refreshed twice a week. The expression of the
osteoblastic phenotype was evaluated at 10 and 20 days from
induction by contemporary monitoring ALP activity and
mineralization by cytochemical staining. For ALP staining,
the cells were washed with DPBS (two times), stained with
a specific dye mixture: 5mg Naphthol-AS-MX phosphate
sodium salt, previously dissolved in 1mL dimethyl sulfoxide,
40mg Fast Red Violet LB, or Fast Blue BB, dissolved in
49mL Tris-HCl Buffer 280mM, pH 9.0 for 30min at 37∘C.
Then, the cells were washed with DPBS (two times), fixed in
4% paraformaldehyde (PFA)/DPBS for 15min, and washed
with ultrapure water (three times). ALP+ cells were stained
in red and nuclei counterstained in blue with Mayer’s acid
hemalum or with DAPI. Formineralization staining, the cells
were washed with DPBS (two times), fixed in 4% PFA/DPBS
for 15min, and washed with ultrapure water (three times).
Calcium mineral deposits were stained for 2min with 2%
Alizarin Red S, pH 6.0, and rinsed with water; calcium
mineralized deposits were stained in red-orange.
2.5. Preparation of PCL Film. Poly(𝜀-caprolactone) (PCL,
CAPA 6800, MW = 80000 g/mol) was kindly supplied by
Perstorp Caprolactones Ltd. (UK).
PCL solution at a concentration of 5%w/v was prepared
by dissolving the polymer in acetone (Sigma Aldrich) at 30∘C
under gentle stirring overnight. PCL film was prepared by
solvent casting of the polymeric solution. For this purpose
8mL of the solution was placed in a 12 cm diameter glass
Petri dish.The casted solutionwas left overnight in an acetone
closed chamber and dried for 1 day under a fume hood.
The dried film was removed from the Petri dish and left
under the fume hood for 24 h and kept under vacuum for
8 h to eliminate residual solvent. Afterwards, the PCL film
was divided into small round disks with a diameter of 14mm,
sterilized overnight in 70% ethanol, and extensively washed
in PBS.
Before cell seeding, all disks were incubated overnight in
GM, in order to promote and facilitate cell adhesion.
2.6. Investigation of Adhesion of hAMSCs on PCL Film.
Adhesion of hAMSCs, PA42-C4 finite clonal line, grown on
the PCL film, was investigated by analysis of fibronectin, the
main cell adhesion protein, and observation of cytoskeleton
fibers, using LSCM. hAMSCs were seeded on PCL films,
positioned in a 24-well plate, at a cell density of 5 ×
103 cells/well, and cultured in GM for 7 days. Afterwards,
samples were washed with DPBS (two times), fixed in
4% paraformaldehyde (PFA/DPBS) for 10min, and washed
with ultrapure water (three times). After permeabilization
with 0.2% PBS 1x/Triton X-100 solution for 15min, samples
were treated with RNAse in 2% bovine serum albumin
(BSA) in order to degrade RNA and to block nonspecific
sites.
Afterwards, samples were incubated with primary anti-
body for fibronectin (Sigma Aldrich) in PBS at 4∘C,
overnight.The following day, primary antibody was removed
by extensive washes with PBS, and secondary antibody Alexa
Fluor 488-conjugated (Invitrogen) was incubated for 1 h at
room temperature in the dark. Cytoskeleton fibers (F-actin)
were stained with phalloidin-Alexa Fluor 635 (Invitrogen)
for 45min a room temperature in the dark. Subsequently,
samples were washed with PBS and observed by Laser
Scanning Confocal Microscopy (LSCM).
2.7. Cell Viability and Proliferation on PCL Film. Viability of
the PA42-C4 clonal line and cytocompatibility on biomaterial
were assessed by staining of the samples with Acridine
Orange (AO). Cells were seeded on PCL film in 24-well
plate at a density of 2 × 104 cells and vitality was assayed
at specific end points (2, 4, 7, 10, 13, and 16 days). Samples
were washed three times with DPBS to remove dead cells
and serum proteins. Afterwards, they were incubated in
4mg/L AO solution (in PBS, 2mL/well) in the dark at room
temperature for 10min and washed three times with PBS.
The cells were immediately observed in phase contrast and
under fluorescence (BP365/FT395/LP397 filter set) with an
Axiovert 200M microscope, and images were acquired with
Axiovision Software on an AxioCam HRC 12 megapixel
camera (Carl Zeiss, Oberkochen, Germany). When stained
with AO, DNA and mitochondria emit metachromatic green
fluorescence (530 nm), and lysosomes, typically present in
suffering or damaged cells, emit red fluorescence (650 nm)
following excitation by ultraviolet (UV) light (365 nm).
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The proliferation rate of the PA42-C4 clonal line on
biomaterial was evaluated via 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl-tetrazolium bromide (MTT; Sigma Aldrich,
USA) assay. Cells were seeded on PCL film in a 24-well
plate at a cell density of 5 × 103 and incubated at 37∘C and
5% CO
2
. After 2, 4, 7, 10, 13, and 16 days of cell culturing,
samples were washed in DPBS and l mL of MTT solution
was added to each well. For conversion of MTT to formazan
crystals by mitochondrial dehydrogenases of living cells,
the plate was incubated at 37∘C for 4 h. For dissolution
of the dark-violet intracellular formazan, the supernatant
was removed and 300 𝜇L of 0.04N HCl in isopropanol, as
solvent, was added per well and plate shaken for 20min. The
optical density was read at a wavelength of 570 nm in cuvette
using BioPhotometer (Eppendorf). The same procedure was
performed for cells cultured on tissue culture polystyrene as
control. Each experimental point was performed in triplicate.
2.8. ALP Assay and Mineralization of hAMSCs on PCL Film.
The PA42-C4 clonal line was seeded on PCL film, positioned
in a 24-well plate, at a concentration of 1 × 105 cells/well.
After a week, the GM was replaced with OM containing the
fluorophore calcein 1 𝜇g/mL and incubated from 7 to 35 days.
At the end of the incubation, the cells were washed with
DPBS (two times), fixed in 4% PFA/DPBS for 15min, washed
with ultrapure water (three times), dried, and preserved at
4∘C until analysis. Each experimental point was performed
in quadruplicate and each experiment repeated three times.
2.8.1. ALP Assay. Each well containing differentiated PA42-
C4 cells on PCL film was incubated with 500𝜇L of 4-
methylumbelliferyl phosphate in 280mM Tris-HCl Buffer,
pH 9.0 for 30min at 37∘C. The reaction was stopped by the
addition of 2.5mL 0.1M NaOH. ALP activity was measured
with a spectrofluorometer LS55 (PerkinElmer) at 365 nm
(𝜆 excitation) and 445 nm (𝜆 emission) and expressed in
𝜇U/ngDNAusing a standard curve of 4-methylumbelliferone
from 50 nM to 10 𝜇M in 280mM Tris-HCl Buffer pH 9.0.
2.8.2. Calcium Mineralized Deposits Assay. Each well con-
taining differentiated PA42-C4 cells on PCL film was incu-
bated with 2mL of 50mM NaEDTA at room temperature,
overnight, in order to solubilize all the calcium mineralized
deposits.Then, the solutionwas transferred into a cuvette and
the fluorescence measured with a spectrofluorometer LS55
(PerkinElmer) at 494 nm (𝜆 excitation) and 517 nm (𝜆 emis-
sion) and expressed in 𝜇g/ng DNA, using a standard curve of
hydroxyapatite from 25 ng/mL to 500mg/mL, solubilized in
50mM NaEDTA.
2.9. Statistical Analysis. For proliferation analysis, statistical
processing was performed during the “log phase” of the
growth curves using (a) the linearity test by Student’s 𝑡-test
and the 𝑅2 coefficient of determination for each regression
and (b) the parallelism test by Student’s 𝑡-test to compare
growth curves of PA42-C4 grown on PCL film with the
growth curve of PA42-C4 grown on PS. For ALP and
mineralized calcium deposits assays the experiments were
carried out in quadruplicate and each experiment repeated
three times. All data were expressed asmeans ± SD. Statistical
differences amongmean values were analyzed using Student’s
𝑡-test.
All the results obtained on the biomaterial were compared
with those obtained by growing the cells on polystyrene (PS)
tissue culture, used as positive control. Data on PCL filmwere
not significantly lower than those obtained on PS which were
considered positive.
3. Results
3.1. Characterization of PA42-C4 Finite Clonal Line. The
plastic-adherent cell population derived fromhuman adipose
tissue, called PA42, was cloned at passage 3. Thirteen clones
were obtained and, among them, clone PA42-C4 was ran-
domly selected for subsequent characterization.
The PA42-C4 cell line showed an elongated and fusiform,
fibroblast-like shape, even if a greater number of cellular pro-
cesses were present compared to the fibroblasts (Figure 1(a)).
The PA42-C4 line did not show growth in soft agar after 4
weeks in culture, demonstrating no malignant transforma-
tion in cells (Figure 1(b)).
Immunofluorescent staining of PA42-C4, observed in
LSCM, has allowed the expression of specific stemness
markers on PA42-C4 surface, such as CD44, CD105, STRO1,
and CD45, to be analyzed. The results obtained highlight the
mesenchymal origin of the cell line, since CD44, CD105, and
STRO1 were intensely stained, in contrast to the hematopoi-
etic lineage marker CD45 which is negative (Figure 2).
The same positivity of the aforesaidmarkers was obtained
with the heterogeneous population of PA42, before cell
cloning (data not shown).
Afterwards, in order to verify their multipotency, both
of the cell lines, PA42 and PA42-C4, were differentiated into
adipogenic and osteogenic phenotypes.
PA42-C4 induction with AM for 10 days resulted in the
presence of small lipid droplets within some cells distributed
around the cellular nucleus, indicating the beginning of the
adipogenic differentiation. After 20 days, induction resulted
in an expanded cell morphology and the accumulation of
multiple intracellular lipid-filled droplets in a significant
fraction of the cells (Figures 3(a), 3(b), and 3(c)).
Osteogenic induction of the PA42-C4 line was assessed
with OMup to 20 days and observed during the entire period
of study, monitoring the ALP expression and the production
of mineralized calcium deposits.
Specifically, after 10 days, some cells began to express
ALP, although with slight or medium intensity, surrounded
by other negative cells. Finally, 20 days after the beginning
of osteogenic induction, almost all of the PA42-C4 cells were
strongly positive for ALP, with only a few, negative, scattered
cells (Figures 3(d), 3(e), and 3(f)). Control cells grown in GM
for the same time did not show any ALP+ cells.
Osteoblastic activity was evidenced by the production
of an osteoid matrix by PA42-C4 cell line cultured in OM,
obtaining an abundant deposition of a mineralized matrix
after 20 and 30 days from induction, in a time-dependent
manner. The area of matrix formation coincided with that
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Figure 1: Representative images of the PA42-C4 clonal cell line grown on PS (a) and on soft agar (b). Phase contrast microscopy. Objective
10x.
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Figure 2: Microscopic observations in LSCM of the main stemness markers on hADSCs. Images show the positive immunofluorescence
staining forCD44, CD105, and STRO1 (conventional green color) and negative immunofluorescence staining forCD45.Nuclei counterstained
with propidium iodide (conventional blue color) and cytoskeleton with phalloidin-Alexa Fluor 635 (conventional red color). Objective 10x.
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Figure 3: Multipotency evaluation of the PA42-C4 cell line. (a, b, c) Representative images of Oil Red O staining at time 0 and after 10 and
20 days of adipogenic induction; the intracellular lipids are in red and nuclei counterstained with Mayer’s acid hemalum are in blue. Images
acquired in brightfield microscopy. Objective 40x. (d, e, f) Representative images of Fast Blue BB staining at time 0 and after 10 and 20 days
of osteogenic induction; ALP+ cells are in blue and nuclei counterstained with propidium iodide are in fluorescent red. Images acquired
in brightfield microscopy for ALP+ cells and in epifluorescence for nuclei. Objective 40x. (g, h, i) Representative images of Alizarin Red S
staining at time 0 and after 20 and 30 days of osteogenic induction; mineralized calcium deposits are in red. Images acquired in phase contrast
microscopy. Objective 40x.
of Alizarin Red S staining. In contrast, control cells grown
in GM for the same time did not show any production of
calcium deposits (Figures 3(g), 3(h), and 3(i)). Phase con-
trast microscopy observations of PA42-C4 cells stained with
Alizarin Red S showed cell death and degeneration, observed
near large mineralized deposits 35 days after osteoinduction.
The same behavior, using AM or OM, was confirmed in
the heterogeneous population of PA42, before cell cloning
(data not shown).
3.2. Preparation of PCL Film. PCL samples for cell culture
experiments were prepared by solvent casting, a technique
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Figure 4: Representative photo of a disk of PCL film used in all of
the experiments.
allowing the obtainment of polymeric films with limited
thickness. This technique involves the dissolution of the
polymer into a suitable solvent, the casting of the solution
into a predefined mold, and the controlled evaporation of
the solvent leaving behind a polymeric film. Homogeneous
PCL samples were successfully prepared by optimizing the
processing parameters, such as the polymer concentration
and the volume of the cast solution. The use of an enclosed
chamber saturated with solvent atmosphere during the dry-
ing process allowed slowing down the solidification process
and thus the obtainment of a more uniform film surface
morphology and thickness.
Specifically, the PCL film utilized for the study has a
thickness of 70.35 ± 13.41 𝜇m (mean ± SD) (Figure 4).
3.3. Analysis of Cell Adhesion andCytoskeletalOrganization on
PCL Film. Attachment of cells is one of the most important
aspects of a scaffold. Microscopic examination in LSCM
of fibronectin, the main cell adhesion protein, of PA42-C4
grown on PCL film for 7 days has permitted the verification
of good adhesion of cells with intense staining localized over
the entire cell surface, showing no qualitative differences with
respect to PA42-C4 cells grown on PS, as control (Figure 5).
Cell morphology and cytoskeletal organization analysis,
determined by F-actin labeling with phalloidin-Alexa Fluor
635, has demonstrated the presence of stress fibers in PA42-
C4 grown for 7 days on PS and on a disk of PCL film.
Cells appeared spindle- or rectangular-shaped with multiple
cellular extensions and exhibited bundles of longitudinal F-
actin filaments usually aligned along themajor axis of the cell
body.No significant differences in the cytoskeletal framework
of PA42-C4 were found between the two supports (Figure 6).
3.4. Analysis of Cell Vitality and Proliferation on PCL Film.
In order to assess the cytocompatibility and viability of cells
on PCL film, the PA42-C4 line was stained with Acridine
Orange and observed by fluorescence microscopy at different
experimental points. The presence of red-orange emitted
fluorescence attributed to lysosomes typically present in
suffering or damaged cells was verified in less than 1% of the
total cells, confirming the suitability of PCL film (Figure 7).
Subsequently, to confirm cell viability and proliferation
on biomaterial, cells attached to film were quantified by
the UV absorbance from the MTT assay, evaluating the
mitochondrial activity, which proportionally increases with
cell proliferation.
This assay showed a consistent increase in absorbance
during all of the experimental period, confirming that good
proliferation of the PA42-C4 on PCL film was achieved
(linear regression 𝑅2 = 0.87). These data are comparable and
not significantly different compared to those obtained with
the PA42-C4 grown on the substrate of control, PS (Figure 8).
3.5. Alkaline Phosphatase (ALP) Activity of PA42-C4 on PCL
Film during Osteogenic Induction. Spectrofluorometric assay
was performed for PA42-C4 grown on PCL film cultivated in
osteogenic medium, in order to assess ALP activity at specific
experimental times, from 0 to 35 days of osteoinduction.
Results have shown a significant increase of the ALP
activity of PA42-C4 induced on PCL film from 14 days
of induction, reaching a maximum value up to 21 days,
correspondent to 41,53𝜇U/𝜇gDNAwith an increase of 7355%
with respect to time 0. This increase substantially remained
constant at 28 days and then decreased after 35 days of
induction.
A similar pattern, not significantly different with respect
to PCL film, was obtained in PA42-C4 induced on PS, as
control, during the entire study period (Figure 9).
TheALP activity was observed in brightfieldmicroscopic,
using a high lamp voltage in order to make the ALP+ cells
visible through the thickness of the PCL film.The ALP+ cells
are evident thanks to the Fast Red Violet LB staining, as
previously described in Materials and Methods (Figure 10).
3.6. Mineralization Analysis of PA42-C4 on PCL Film during
Osteogenic Induction. The formation of mineralized extra-
cellular matrix was assessed by spectrofluorometric assay,
quantifying the production of calcium deposits at different
experimental points, from 0 to 35 days of osteoinduction.The
quantity of calcium deposits obtained by the seeded cells and
induced on PCL filmwas compared to that obtained for PA42
differentiated on substrate control, PS.
The obtained results have shown a significant increase in
the production of calcium nodules by PA42-C4 induced on
PCL film starting at 14 days, reaching the maximum value at
35 days, corresponding to 111,53 ng/𝜇g DNA, with an increase
of 13337% with respect to time 0.
A similar pattern, not significantly different with respect
to PCL film, was obtained in PA42-C4 induced on PS, as
control, during the entire study period (Figure 11).
The production of calcium deposits was observed by
microscopic observation acquired in LSCM; in fact, calcium
nodules are evident thanks to the addition of fluorophore
calcein to the osteogenic medium during the entire experi-
mental period (Figure 12).
4. Discussion
Multipotent cells derived from adipose tissue represent an
attractive tool in regenerative medicine. The higher number
of hAMSCs yielded from lipoaspirates, able to differentiate
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Figure 5: Microscopic observation in LSCM of fibronectin (Alexa Fluor 488, conventional green color) of PA42-C4 grown on PCL film (a)
and on PS (b). Nuclei counterstained with propidium iodide (conventional blue color). Objective 20x.
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Figure 6: Microscopic observation in LSCM of cytoskeleton fiber (Alexa Fluor 635, conventional red color) of PA42-C4 cells grown on PCL
film (a) and on PS (b). Nuclei counterstained with propidium iodide (conventional blue color). Objective 20x.
into mesodermal lineages (osteogenic, adipogenic, chondro-
genic, and myogenic phenotypes) as well as the interesting
immunomodulating properties, implicit in MSCs, suggests
that they can be considered very promising for future appli-
cation in cell-based therapy.
In this study, we have isolated and characterized a single-
cell-derived clone of hAMSCs, carried out for investigating
the potential of a homogeneous population of MSCs in order
to obtain more coherent results with respect to the use of a
heterogeneous subset of cells obtained from adipose tissue,
as discussed by Guilak et al. [41]. Our results have shown that
the clone PA42-C4 has maintained the multipotentiality of
the heterogeneous population PA42, demonstrating its own
capacity to differentiate into the adipogenic and osteogenic
phenotypes, as assessed by the cytochemical staining per-
formed on cells, properly induced with specific differen-
tiating media. Moreover immunofluorescence analysis has
permitted the verification of the presence of the principal
markers largely recognized to be expressed on the surface of
MSCs, specifically CD44, CD105, and STRO1, confirming the
validity of our clone for further experiments.
Subsequently, we have analyzed the in vitro behavior of
the clonal human cell line, PA42-C4, in combination with
PCL film, since PCL has been widely investigated for tissue
regeneration applications. Nevertheless, there are no studies
in literature which take into consideration the above cellular
type and 2DPCLfilm. So, we have demonstrated the potential
of this cell-biomaterial model for future application in bone
tissue engineering.
PCL has good biocompatibility, inexpensive production
routes, tuneable biodegradation kinetics and mechanical
properties, and good blend-compatibility. In addition, by way
of its superior rheological properties and ease of shaping,
PCL has incredible processing versatility being suitable for
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Figure 7: Representative images of PA42-C4 grown on PCL film at different experimental points (2–16 days) and stained with Acridine
Orange.The nuclei andmitochondria appear green, while if cells are damaged or suffering, lysosomes should appear red-orange fluorescence
colored. Objective 20x.
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Figure 8: Analysis of the proliferation of PA42-C4 grown on PCL
film (red) and on PS (blue), carried out at specific experimental
points (2–16 days), using theMTTassay.The relative absorbance val-
ues were measured at 570 nm.The statistical analysis was performed
by linearity test and parallelism test between the two regression lines.
Image A shows a representative disk of PCL with violet crystals of
formazan produced fromMTT conversion by PA42-C4.
a wide range of techniques investigated for tissue engineering
scaffold fabrication [33]. Indeed, a number of processing
techniques have been applied to process PCL into scaffolds,
such as particulate leaching, phase separation, textiles, and
additive manufacturing techniques. This allows designing
and manufacturing PCL scaffold with tailored structural
features at the macro-, micro-, and nanoscale levels, such as
foam [42], microfiber constructs with a predefined network
of pores [43], and nanofibrous assemblies with high surface
area [44].
The ability of cells to recognize and interact with the
selected support represents the first essential step, without
which processes such as cell proliferation, migration, and
differentiation would not be possible. It is generally accepted
that well-formed actin stress fibers and adhesion would infer
stable attachment and cell survival on material surfaces [45].
For that purpose, in our study, we have verified the expression
of the adhesion protein fibronectin and the organization
and morphology of the cytoskeleton of PA42-C4 cells grown
on PCL film, demonstrating the achievement of good cell
adhesion to the biomaterial. Our results have not shown any
significant differences compared to those observed in cells
grown on PS, used as control.
Afterwards, we assessed cell viability/proliferation on
biofilm in order to confirm not only the cytocompatibility
of the biomaterial, but also that PA42-C4 cells are able to
proliferate on PCL film. We have found that the proliferation
process increases in a time-dependent manner, with no
significant differences compared to cells grown on PS, as
control, bringing evidence that PCL film does not affect
PA42-C4 proliferation capacity.
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Figure 9: Analysis of ALP activity in PA42-C4 induced on PCL film
(red) and on PS (blue) from 0 to 35 days. The values are the mean ±
SD of three independent experiments. Significance was obtained by
Student’s 𝑡-test, comparing the value of ALP activity to the different
time points with respect to time 0, for cells induced on PCL film
or on PS. ∗𝑝 < 0.001 versus respective time 0; #𝑝 < 0.005 versus
respective time 0; §𝑝 < 0.05 versus respective time 0.
50𝜇m
Figure 10: Representative observations of the PA42-C4 line on PCL
film induced in osteogenic medium up to 35 days. ALP+ cells are
stained with Fast Red Violet LB (red color) and nuclei with DAPI
(fluorescent blue color). Image acquired in brightfield microscopy
for ALP+ cells and in epifluorescence for nuclei. Objective 20x.
Finally, since bone regeneration represents our target, to
understand the osteogenic differentiation of PA42-C4onPCL
film and demonstrate the potential of our proposed model,
we have evaluated ALP activity and calcium deposition; these
parameters are widely used as markers for early and late
differentiation of osteoblast-like cells, respectively. Results
obtained have indicated that PCL film has supported pheno-
typic differentiation of hAMSCs by triggering the enzyme’s
activity and the production of a mineralized extracellular
matrix, confirming the suitability of the aforementioned
biomaterial to ensure the osteoblastic differentiation process.
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Figure 11: Analysis of mineralized calcium deposits in PA42-C4
induced on PCL film (red) and on PS (blue) from 0 to 35 days. The
values are the mean ± SD of three independent experiments. The
significance was evaluated by Student’s 𝑡-test comparing the value
of calcium deposits at different experimental points with respect to
time 0 for cells induced on PCL film or on PS. ∗𝑝 < 0.001 versus the
respective time 0; #𝑝 < 0.005 versus the respective time 0.
50𝜇m
Figure 12: Representative observations acquired in LSCM of the
PA42-C4 line on PCL film induced in osteogenic medium up to 35
days. Calcium deposits are stained with calcein (conventional green
color) and nuclei with propidium iodide (conventional red color).
3D projection of Z-Stacks of 23 optical sections with an interval of
3 𝜇m from each other. Objective 20x.
Overall, although the results obtained on PCLfilm are not
significantly different from those obtained by growing and
inducing cells on PS, used as control, the encouraging results
of this study in terms of cell adhesion, proliferation, and dif-
ferentiation of hAMSCs on PCL filmmake the hAMSCs/PCL
film a suitable model for further investigation, opening new
possibilities for the development of engineered constructs
with tailored structure, optimized for the regeneration and
3D in vitromodels of bone tissue.
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Current literature reports the development of numerous
techniques of surface modification to increase cell adhe-
sion on synthetic polymers by modifying polymer sur-
face morphology (roughness) and/or hydrophilicity and by
immobilizing specific ECM derived peptides. In fact, it is
well demonstrated that these variations could improve the
interaction between cell and substrate, high cell viability, and
enhance bone formation capability [36, 38, 45–47].Moreover,
over the last decade, since polymers lack osteoconductiv-
ity, considerable attention has been directed toward their
combination with natural or synthetic bioceramics, such as
hydroxyapatite or calcium phosphate. This strategy has per-
mitted the creation of many composite scaffolds that imitate
the natural structure of bone with superior osteoconductive
property, stimulating MSCs to foster a favorable osteogenic
microenvironment [31, 40, 48, 49].
Keeping all of this inmind, it seems, therefore, reasonable
to carry out further studies to improve the properties of our
proposedmodel, hAMSCs/PCL film, for future application in
bone tissue regeneration.
5. Conclusion
This study has demonstrated that hAMSCs can be grown
and induced to differentiate in osteoblastic cells on PCL
film prepared by solvent casting, suggesting and promoting
research of new strategies to enhance and maximize the
cellular reply and differentiation on the substrate for future
use in bone tissue engineering applications. However, it is
still evident that in order to achieve more conclusive results
further in vivo studies are needed to optimize the biological
mechanism for osseous integration and regeneration using
the proposed cell-biomaterial model.
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